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Clostridial  neurotoxins,  tetanus  toxin (Ten) and the 
seven related  but  serologically distinct botulinal  neuro- 
toxins (BoNT/A to BoNT/G), are  potent  inhibitors of syn- 
aptic vesicle exocytosis in nerve endings. Recently it 
was  reported  that the light  chains of clostridial  neuro- 
toxins act as zinc-dependent metalloproteases which 
specifically cleave synaptic  target  proteins such as 
synaptobrevinNAMPs, HPC-llsyntaxin (BoNT/Cl), and 
SNAP-25 (BoNT/A). We show here that BoNT/E, like 
BoNT/A, cleaves SNAP-25, as generated by in vitro trans- 
lation or by expression in Escherichia coli. BoNT/E 
cleaves the ArglBO-IlelB1  bond.  This s te is different from 
that of BoNT/A, which cleaves SNAP-25 between the 
amino  acid residues Glnls7  and  ArglSs.  These  findings 
further support the view that clostridial neurotoxins 
have evolved from an ancestral  protease  recognizing  the 
exocytotic fusion  machinery of synaptic vesicles 
whereby  individual  toxins  target  different  members of 
the membrane  fusion  complex. 
Clostridial  neurotoxins are generated as single-chain poly- 
peptides (M, 150,000) that are proteolytically  activated  into  the 
dichain toxins in which the L1 chains (M, 50,000) remain 
linked to the H chains (M, 100,000)  via a disulfide  bond 
(Niemann, 1991). In contrast t o  BoNT/A, which is produced  by 
a proteolytic strain and thus released as a n  active di-chain 
toxin, BoNT/E is released from a nonproteolytic strain as a 
single-chain  derivative  (DasGupta  and Rasmussen, 1983). Af- 
ter uptake  into the host  organism BoNT/E is  activated  by  host 
proteases.  Activation  can  also be achieved in. vitro by means of 
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trypsin  incubation  (Sathyamoorthy and DasGupta, 1985). The 
H chains  mediate  neuroselective  binding,  internalization, in- 
traneuronal sorting, and finally translocation of the corre- 
sponding L chains  from an acidic  compartment  into  the cytosol. 
Here, the L chains act as metalloproteases that specifically 
cleave  synaptic  proteins that are directly involved in the ve- 
sicular  release of neurotransmitters, Thus TeTx, BoNTB, 
BoNT/D, and BoNTE’ hydrolyze  synaptobrevin  isoforms 
(Schiavo et al., 1992,  1993;  Link et al., 1992).’ BoNT/Cl  spe- 
cifically degrades HPC-llsyntaxin (Blasi et al., 1993a), and 
BoNT/A proteolyzes the  synaptic  protein  SNAP-25  (Blasi et al., 
1993b).  Sollner et  al. (1993)  have  reported that synaptobrevin, 
syntaxin, and SNAP-25 form a complex that binds the cytosolic 
proteins NSF and CY-, p-, y-SNAPS. The latter proteins were 
shown  to  be  required  for  various  intracellular  fusion  events  in 
which NSF acts as an ATPase (Rothman and Orci, 1992). In 
this  study,  we  demonstrate that BoNT/E cleaves SNAP-25 be- 
tween Argla0 and Ilelal. This site differs from the BoNT/A 
cleavage  site  shown here to be the Gln197-Arg198 bond. 
EXPERIMENTAL. PROCEDURES 
Neurotoxins-BoNTIA was isolated from the Hall strain according  to 
Sugii and Sakaguchi (1975). For production of BoNT/E, the Beluga 
strain was  used  following the procedure of DasGupta and Rasmussen 
(1983). For proteolytic activation, single-chain BoNT/E (500 nM final 
concentration) in 500 pl of 50 mM sodium acetate buffer,  pH 6.0, con- 
taining 0.2 M NaCI,  was incubated for  30  min at 37  “C under shaking in 
the presence of 280 milliunits of agarose-immobilized trypsin (Pierce 
Chemical  Co.).  After incubation, soybean trypsin inhibitor (5 p ~ ,  final 
concentration; Boehringer Mannheim) was added, the agarose beads 
were  removed  by  two consecutive centrifugation steps (10,000 x g, 10 
min), and activated BoNT/E  was recovered in the supernatant. BoNT/E 
and BoNTIA were  reduced by incubation for  30 min at 37 “C in 10 mM 
(final concentration) dithiothreitol. 
Bacterial Expression of SNAP-25 and Digestion with BoNTIE and 
BoNTIA-A clone encoding SNAP-25 was isolated from a rat brain 
cDNA library by PCR using the two primers 5”CGCGGATCCATG- 
GC(C/G)GA(A/G)GACGC(A/G)GA(C/T)ATG-3’ and 5”CGCAGATC- 
TAACCACT(TIG)CC(CIG)AGCATC’R”3’. The amplified fragment was 
digested  with BamHI and BgZII,  cloned into the BamHI site of pGEX-ST 
(Pharmacia LKB  Biotechnology Inc.), and sequenced by the chain ter- 
mination method (Sanger et al., 1977). The deduced amino acid se- 
quence  was identical to the mouse  SNAP-25  sequence  published  previ- 
ously (Oyler et al., 1990). For in vitro transcription/translation, the 
SNAP-25  gene  was  recovered as a BamHI-EcoRI fragment and cloned 
into pSP72 (Promega, Heidelberg, Germany). 
For  expression of an authentic SNAP-25  polypeptide, we first intro- 
duced a singular HpaI blunt-end site following the last codon of the 
used 5’-CTCTGAATTCGCAATTAAGGAGATAATAGGTATGGCCGA- 
SNAP-25  open reading frame. As an upstream primer in the PCR,  we 
GGACGCAGACATGCGT-3‘. This primer provided the EcoRI site for 
cloning and a Shine-Dalgarno sequence for ribosomal binding. 5’- 
CTCTCGTCGACGTTAACACCACTTCCCCAGCATC’MTGTTGCAC - 3’, 
providing the  HpaI site, was  used as  the 3’-primer. A set of  two  comple- 
mentary oligonucleotides  encoding the sequence  PPTPGHHHHHH and 
a translational termination signal was inserted into the HpaI site. 
Recombinant clones were verified by  DNA sequencing. To express 
SNAP-25,  we transferred the EcoRI-Sal1 fragment into pQE3 (Diagen, 
Diisseldorf, Germany). Induction and isolation of the recombinant 
SNAP-25 protein via nickel-nitrilotriacetic acid agarose (Ni-NTA-aga- 
rose,  Diagen)  were  performed  according  to the manufacturer’s instruc- 
tions. For  digestion  with  reduced activated BoNT/E or BoNT/A,  30 pg of 
purified  SNAP-25 (or its 9.5-kDa C-terminal fragment) were incubated 
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for 60 min at 37 "C in 50 pl of 20 ~ l l ~  HEPESKOH,  pH 7.0, containing 
100 m NaCl and 200 m (final concentration) activated reduced 
BoNT/E or BoNT/A. Aliquots were analyzed on 15% SDS-polyacryl- 
amide  gels  according to Laemmli (1970). 
Other Methds-SNAP-25 peptides and cleavage products  were iso- 
lated by reverse phase chromatography using a Nucleosil 5-)lm C8 
c o l u m n  (250 x 4 mm) from Macherey and Nagel ( m e n ,  Germany). 
Amino acid sequences  were determined on a model 473A protein se- 
quencer from Applied Biosystems (Foster City, CA). 
In Vitro hnscr ipt ion I Zhmdatio-Radiolabeled SNAP-25 was o b  
tained as a substrate for BoNT/E and BoNT/A applying the combined 
TN'Pkoupled reticulocyte lysate  system from Promega according to 
manufacturer's instructions. For in vitro synthesis of the BoNTlE L 
chain, we amplified the corresponding gene fragment using the two 
primers 5 ' - C A C A G G A T C C A T G C C A 3 '  and 
mosomal DNA (Poulet et al., 1992) as template.  The  fragment  was cut 
with BamHI and  Hind11  and cloned under control of the  SP6 promoter 
into pSP73  (Promega). pBN4, encoding the  entire L chain of BoNT/A 
under control of the  SP6 promoter (Binz et al., 1990), was used for 
production of  BoNT/A L chain-specific mRNk 
5'-CTCTCAAGC'ITAGGCC'ITATGCC'Illl'ACAGAAAC-3' and chro- 
RESULTS AND DISCUSSION 
We have recently identified SNAP-25 as the substrate of 
BoNTIA (Blasi et al., 1993b). Comparative studies on the action 
of  BoNT/A and BoNT/E on the  vertebrate neuromuscular  junc- 
tion  demonstrated that both types of neurotoxin act in a similar 
manner with  respect to blocking spontaneous miniature end- 
plate potentials (Molgo et al., 1989,1990). Therefore, we exam- 
ined whether BoNT/E, like BoNT/A, proteolyzes SNAP-25. For 
this purpose, we generated radiolabeled SNAP-25 by combined 
in  vitro transcriptiodtranslation. As shown in Fig. lA (lane 3 ), 
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FIG. 1. Cleavage of SNAP-26 by BoNTE and BoNTA. A, cleavage 
by recombinant BoNT/E and BoNTIA L chains. SNAP-25 was  translated 
in  the presence of [35Slmethionine and incubated for 60 min a t  37 "C 
with  aliquots of  BoNTlE (lane 5) or BoNTIA (lane 4 )  that were  gener- 
ated by in vitro transcriptiodtranslation but  in  the absence of labeled 
amino acids. To control for the expression of the BoNT/E and BoNT/A L 
chains, translation of the L chains  was also performed in  the presence 
of [%]methionine, resulting  in  the  appearance of major translation 
products of the expected size (lane 1, BoNT/A L chain; lane 2, BoNT/E 
L chain). Note that  in addition to SNAP-25, an unidentified translation 
product of lower mobility is  generated. Samples  were  analyzed by SDS- 
polyacrylamide gel electrophoresis on 15% gels and processed by auto- 
radiography. B,  cleavage of SNAP-25 by trypsin-activated BoNT/E de- 
rived from C. botulinum. In vitro translated SNAP-25 was incubated at 
37 "C for 60 min either alone (lane 1 )  or with the following additions: 
lane 2, BoNT/E (40 nM final  concentration); lane 3, BoNT/E + 20 mM 
dipicolinic acid (DPD); lane 4, BoNT/E + 20 m o-phenanthroline 
(PTL); lane 5, BoNT/E + 20 m EDTA, lane 6, heat-inactivated BoNTlE 
(IO min a t  100 "C); lane 7, BoNT/E + 5 soybean trypsin inhibitor; 
lane 8.22.5 milliunits of trypsin; lane 9, trypsin (22.5 milliunita) treated 
with 5 soybean trypsin inhibitor. Samples were separated on a 12% 
polyacrylamide gel, and  bands were  visualized by autoradiography. 
a major translation product was generated that exhibited an 
apparent molecular mass of 28 kDa, similar to that of native 
SNAP-25. This  translation product was then incubated  with 
BoNT/E L chain  that was generated by in  vitro transcription/ 
translation from the cloned gene (Poulet et al., 1992) in  the 
absence of radiolabeled amino acids. As shown in Fig. L4 (lane 
4 ) incubation with  recombinant BoNT/E L chain resulted  in  the 
generation of a product of smaller molecular weight (M, shift 
approximately 3,000) demonstrating  that SNAP-25 is proteo- 
lyzed. In a parallel  incubation, SNAP-25 was  also  incubated 
with  recombinant L chain of  BoNT/A. In agreement  with  our 
previous observations  (Blasi et al., 1993b), this also  resulted in 
cleavage of SNAP-25 (lane 4) .  However, the major  fragment 
generated by BoNT/A L chain was larger  than  that generated 
by BoNT/E L chain, indicating that  the respective cleavage 
sites  are different. Together our data  demonstrate  that both 
BoNT/E and BoNT/A hydrolyze SNAP-25. Because the BoNT/E 
L chain  was  generated by in  vitro transcriptiodtranslation of 
cloned DNA, a contamination by foreign proteases is excluded. 
In  the  next experiments, we studied whether SNAP-25 was 
also cleaved when BoNT/E was used that was isolated from 
Clostridium botulinum and activated by trypsin-containing 
beads prior to the incubation. Again, radiolabeled SNAP-25 
generated by in  vitro translation was used as a substrate. As 
shown in Fig. 1B (lune 21, activated BoNT/E generated a cleav- 
age product of SNAP-25 that was of a size similar to that 
observed after incubation  with the recombinant L chain. No 
cleavage of SNAP-25 was observed even when it was directly 
incubated  with trypsin beads  (regardless of whether soybean 
trypsin inhibitor  was present or not; lanes 8 and 9) ,  indicating 
that BoNT/E-induced cleavage is not  due to residual  trypsin in 
the incubation  mixture. In  contrast, BoNT/E cleavage of 
SNAP-25 was still observed even when excess amounts of soy- 
bean trypsin inhibitor were present (lane 7). However,  BoNT/ 
E-induced proteolysis of SNAP-25 was abolished in  the pres- 
ence of various metal ion chelators or when the toxin was 
heat-inactivated (lanes 34). Together these  data show that 
trypsin-activated BoNT/E, as purified from C. botulinum was 
free of contaminating proteases and could thus be used for 
determination of the cleavage site. 
To obtain larger amounts of substrate, we engineered a 
SNAP-25 gene that encoded a C-terminal His6 tag preceded by 
a unique IgA-protease cleavage site (PPTP; Pohlner et al. 
(1992)). This mutant gene  was  expressed in E. coli M15 under 
control of a tightly  regulated promoter. The His tag allowed 
purification of recombinant SNAP-25 by chromatography on 
Ni-NTA-agarose. As shown in lane 1 of Fig. 2, the  largest mo- 
lecular species in  the  eluate fraction corresponded in size to 
that of the full-length  recombinant polypeptide. Furthermore, 
microsequencing revealed that it contained the  authentic N- 
terminal sequence originally reported by Oyler et ul., (1989). 
This material was further purified by reverse phase HPLC 
(lane 2 )  and used as a substrate for trypsin-activated and re- 
duced BoNT/E (lane 4 )  and reduced BoNT/A (lane 3) .  The size 
of the individual larger sized cleavage products correlated  with 
that previously observed in  the in  vitro approach. Furthermore, 
these  fragments failed to bind to the Ni-NTA-agarose, indicat- 
ing that both toxins cleaved peptide bonds close to the C-ter- 
minal end  (data not shown). The arrowheads point to positions 
of the small  C-terminal  fragments, which, however, were barely 
detectable on the Coomassie Blue-stained gel. 
In addition to full-length SNAP-25, some lower molecular 
weight species co-purified on the Ni-NTA-agarose column, in- 
dicating that  they represented  C-terminal fragments carrying 
the His6 tag. These  peptides were not obtained when the re- 
combinant E. coli cells were lysed with 6 M guanidinium hydro- 
chloride (not shown). The  smallest of them (M, 9,500) was  also 
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FIG. 2. Cleavage of E. coli-expressed SNAP-25 by BoNWE and 
BoNTlA. Recombinant E. coli cells expressing  the SNAP-25 gene  under 
control of an  isopropyl-1-thio-P-D-galactopyranoside-inducible promoter 
were lysed under physiological conditions, and SNAP-25 carrying a 
C-terminal  His6 tag  was bound  via Ni-NTA-agarose according to the 
protocols of the  manufacturer. Lane 1 shows that full-length SNAP-25 
and  a set of C-terminal  fragments  were  eluted from Ni-NTA agarose. 
The  subfragments  were  subsequently  purified by reverse  phase  HPLC. 
Microsequencing of the  largest  (full-length)  and  smallest  polypeptides 
yielded the  sequences  indicated on the left. Full-length  SNAP-25  was 
digested with purified reduced BoNT/A (lune 3) and with reduced 
BoNTIE, previously  activated  with  trypsin (lune 4) .  Samples  were  ana- 
lyzed on a 15% polyacrylamide gel and  stained  with  Coomassie  Brilliant 
Blue. Arrowheads indicate the positions of the C-terminal peptides 
released by the  individual L chains.  Molecular  mass  markers  are  shown 
on  the right. 
isolated by HPLC and microsequenced. The N-terminal se- 
quence  indicated that it originated from proteolytic degrada- 
tion  affecting the Arg135-Arg136 bond. This molecular species 
was cleaved as efficiently as full-length SNAP-25. 
Taking  into account that  the presence of the C-terminal His6 
tag does not  interfere with proteolysis, our  data  suggest  that 
neither BoNT/E nor BoNT/A require  the presence of the  au- 
thentic N and C termini. We have shown  recently t h a t   T e e ,  
BoNT/D, and BoNT/F cleave rat synaptobrevin  2 a t  different 
sites2  Each of the toxins required about 10 residues at  the 
C-terminal  side of the scissile bond. In each instance, however, 
optimum  cleavability required  the presence of more distal N- 
terminal sequences.2 It  will be interesting to see whether 
BoNT/E and BoNT/A, cleaving SNAP-25 a t  different peptide 
bonds, have  related  substrate  requirements.  In  this context, it  
is of interest that the N-terminal fragment generated from 
SNAP-25 by cleavage with BoNT/A still  serves as a substrate 
for BoNT/E (data  not shown). 
For isolation of the  C-terminal cleavage products, we applied 
reverse phase HPLC. Panel A of Fig. 3 shows the elution profile 
obtained for full-size untreated SNAP-25. Upon cleavage with 
BoNT/E (panel B ) ,  the  parental  peak  was shifted from 27.33 to 
27.03 min and a new peak  eluting at retention  time of 13.32 
min appeared. Material underlying this peak was collected. 
Microsequencing over 10 cycles produced the sequence 
IMEKADSNKT. Thus, BoNT/E cleaves SNAP-25 at the ArglS0- 
Ile'*l bond. 
In addition, we collected the C-terminal fragment  generated 
by treatment with BoNT/A (panel C ) .  This fragment eluted 
after 11.52 min from the HPLC column. Microsequencing 
yielded the sequence RATKMLGSGV, whereby the valine  resi- 
due  stems from the introduction of the HpaI site originally  used 
to introduce the His6 tag.  Thus, BoNT/A cleaves SNAP-25 a t  
the Gln197-Arg19R bond, releasing only a nonapeptide as a C- 
terminal cleavage product. 
In  contrast  to  the  other  targets of clostridial neurotoxins 
(synaptobrevins and  syntaxins), SNAP-25 does not  contain a 
transmembrane  anchor domain but associates  with mem- 
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Frc. 3. HPLC profiles of SNAP-25 before and  after  digestion 
with BoNTlE and BoNTlA. HPLC-purified full length SNAP-25 was 
trypsin-activated,  reduced BoNTIE ( B )  or 200 nM reduced BoNT/A (C). 
incubated for 60 min a t  37 "C alone (A) ,  in  the presence of 200 nM 
Samples  were  analyzed by reverse  phase HPLC. Peak  fractions  were 
collected, and  underlying  material  was  subjected  to microsequencing. 
Amino acid sequences specify the N-terminal sequences of the frag- 
ments. 
branes  through palmitoylation of 1 or more of the 4 cysteine 
residues between positions 82  and 92 (Hess et al., 1992). There- 
fore, cleavage with BoNT/E and BoNT/A will not affect mem- 
brane association of SNAP-25. Since both BoNT/E and BoNT/A 
efficiently block exocytotic release of neurotransmitters, our 
data suggest  a  direct role of the C-terminal domain of SNAP-25 
in  this process. Whereas  it  is unlikely that cleavage of SNAP-25 
by BoNT/A results  in a dramatic change of the  tertiary struc- 
ture  (the  residual  fragment  is  still cleaved by BoNT/E), it  is 
likely that  the C-terminal domain interacts with other pro- 
teins. Recently, Sollner et al. (1993) have reported that SNAP- 
25, synaptobrevin, and  HPC-llsyntaxin  constitute  the essential 
components of a docking-fusion machinery that binds other 
soluble cytosolic proteins,  NSFs and a, p, y-SNAPS, in an ATP- 
dependent  manner. Both NSFs and SNAPS are associated with 
this complex in a well defined stoichiometric ratio (Wilson et 
al., 1992) and have been shown earlier to be required for a 
series of intracellular fusion events  (Rothman  and Orci, 1992). 
It  is  intriguing  to speculate that  the clostridial neurotoxins 
have evolved from one ancestral gene encoding a  protease that 
selectively cleaved synaptobrevin and  thus blocked neurotrans- 
mitter release. During evolution, the individual neurotoxins 
have diverged, some of them (TeTx/BoNT/B, BoNTD, and 
BoNT/F) cleaving still  the  same  substrate, however at different 
peptide bonds. Yet other clostridial  neurotoxins have developed 
specificity for other members of the  same exocytotic protein 
1620 Botulinum Neurotoxin Type E Cleaves SNAP-25 
complex. Thus BoNT/Cl hydrolyzes HPC-Vsyntaxin,  whereas 
BoNT/E and BoNT/A degrade SNAP-25, again at different 
sites. The detection of cellubrevin, a “en-sensitive synapto- 
brevin homologue present  in  all eukaryotic cells examined (Mc- 
Mahon et al., 19931, suggests  that a similar protein complex 
regulates constitutive exocytosis in  all eukaryotic cells. It will 
be interesting  to  see  whether HPC-Vsyntaxin or SNAP-25 iso- 
forms can be detected in  these cells as  substrates for BoNT/Cl, 
BoNT/A, and BoNT/E. 
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